Vanguard Group’s Cyclacel Pharmaceuticals CYCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-86,949
| Closed | -$30.8K | – | 4506 |
|
|
2023
Q3 | $30.8K | Hold |
86,949
| – | – | ﹤0.01% | 4461 |
|
|
2023
Q2 | $51.2K | Hold |
86,949
| – | – | ﹤0.01% | 4454 |
|
|
2023
Q1 | $49.6K | Hold |
86,949
| – | – | ﹤0.01% | 4469 |
|
|
2022
Q4 | $58K | Sell |
86,949
-84,514
| -49% | -$56.4K | ﹤0.01% | 4431 |
|
|
2022
Q3 | $250K | Sell |
171,463
-155,806
| -48% | -$227K | ﹤0.01% | 4380 |
|
|
2022
Q2 | $353K | Hold |
327,269
| – | – | ﹤0.01% | 4366 |
|
|
2022
Q1 | $998K | Hold |
327,269
| – | – | ﹤0.01% | 4209 |
|
|
2021
Q4 | $1.27M | Sell |
327,269
-389
| -0.1% | -$1.51K | ﹤0.01% | 4194 |
|
|
2021
Q3 | $1.73M | Hold |
327,658
| – | – | ﹤0.01% | 4105 |
|
|
2021
Q2 | $1.94M | Buy |
327,658
+27,689
| +9% | +$164K | ﹤0.01% | 3969 |
|
|
2021
Q1 | $2.13M | Buy |
299,969
+284,511
| +1,841% | +$2.02M | ﹤0.01% | 3844 |
|
|
2020
Q4 | $121K | Buy |
+15,458
| New | +$121K | ﹤0.01% | 4127 |
|
|
2020
Q2 | – | Sell |
-106,172
| Closed | -$41K | – | 4081 |
|
|
2020
Q1 | $41K | Hold |
106,172
| – | – | ﹤0.01% | 4010 |
|
|
2019
Q4 | $71K | Hold |
106,172
| – | – | ﹤0.01% | 4034 |
|
|
2019
Q3 | $42K | Hold |
106,172
| – | – | ﹤0.01% | 4094 |
|
|
2019
Q2 | $57K | Sell |
106,172
-7,985
| -7% | -$4.29K | ﹤0.01% | 4097 |
|
|
2019
Q1 | $107K | Buy |
114,157
+193
| +0.2% | +$181 | ﹤0.01% | 4006 |
|
|
2018
Q4 | $69K | Sell |
113,964
-262,933
| -70% | -$159K | ﹤0.01% | 4039 |
|
|
2018
Q3 | $516K | Buy |
376,897
+4,400
| +1% | +$6.02K | ﹤0.01% | 3847 |
|
|
2018
Q2 | $529K | Sell |
372,497
-1,658
| -0.4% | -$2.36K | ﹤0.01% | 3815 |
|
|
2018
Q1 | $506K | Buy |
374,155
+26,709
| +8% | +$36.1K | ﹤0.01% | 3782 |
|
|
2017
Q4 | $604K | Buy |
347,446
+89,026
| +34% | +$155K | ﹤0.01% | 3702 |
|
|
2017
Q3 | $473K | Buy |
258,420
+219,755
| +568% | +$402K | ﹤0.01% | 3763 |
|
|
2017
Q2 | $146K | Sell |
38,665
-107,840
| -74% | -$407K | ﹤0.01% | 3947 |
|
|
2017
Q1 | $501K | Buy |
146,505
+58,314
| +66% | +$199K | ﹤0.01% | 3752 |
|
|
2016
Q4 | $467K | Buy |
88,191
+41,307
| +88% | +$219K | ﹤0.01% | 3744 |
|
|
2016
Q3 | $281K | Sell |
46,884
-28,902
| -38% | -$173K | ﹤0.01% | 3851 |
|
|
2016
Q2 | $380K | Sell |
75,786
-833,667
| -92% | -$4.18M | ﹤0.01% | 3836 |
|
|
2016
Q1 | $351K | Sell |
909,453
-12,481
| -1% | -$4.82K | ﹤0.01% | 3857 |
|
|
2015
Q4 | $461K | Buy |
921,934
+41,382
| +5% | +$20.7K | ﹤0.01% | 3851 |
|
|
2015
Q3 | $449K | Buy |
880,552
+3,775
| +0.4% | +$1.93K | ﹤0.01% | 3883 |
|
|
2015
Q2 | $702K | Buy |
876,777
+57,165
| +7% | +$45.8K | ﹤0.01% | 3764 |
|
|
2015
Q1 | $738K | Buy |
819,612
+140,452
| +21% | +$126K | ﹤0.01% | 3710 |
|
|
2014
Q4 | $475K | Buy |
679,160
+27,500
| +4% | +$19.2K | ﹤0.01% | 3748 |
|
|
2014
Q3 | $1.98M | Buy |
651,660
+14,470
| +2% | +$44K | ﹤0.01% | 3270 |
|
|
2014
Q2 | $1.96M | Buy |
637,190
+36,000
| +6% | +$111K | ﹤0.01% | 3270 |
|
|
2014
Q1 | $2.21M | Buy |
601,190
+47,499
| +9% | +$175K | ﹤0.01% | 3176 |
|
|
2013
Q4 | $2.23M | Buy |
553,691
+10,932
| +2% | +$44K | ﹤0.01% | 3144 |
|
|
2013
Q3 | $2.32M | Buy |
542,759
+196,423
| +57% | +$839K | ﹤0.01% | 3079 |
|
|
2013
Q2 | $1.02M | Buy |
+346,336
| New | +$1.02M | ﹤0.01% | 3307 |
|